AFC-HD AMS Life Science Co., Ltd. (TYO:2927)
Japan · Delayed Price · Currency is JPY 825.00
-22.00 (-2.60%)
Nov 6, 2026, 3:30 PM JST
AFC-HD AMS Life Science Ratios and Metrics
Market cap in millions JPY. Fiscal year is September - August.
Millions JPY. Fiscal year is Sep - Aug.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
| 12,012 | 12,711 | 12,176 | 11,714 | 11,121 | 10,805 | |
Market Cap Growth | 1.24% | 4.39% | 3.94% | 5.33% | 2.93% | -33.33% |
Enterprise Value | 25,889 | 27,000 | 25,268 | 22,965 | 19,690 | 18,335 |
Last Close Price | 825.00 | 873.00 | 828.05 | 766.02 | 707.65 | 661.55 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
PE Ratio | 9.96 | 10.61 | 8.41 | 9.36 | 10.09 | 14.70 |
PS Ratio | 0.35 | 0.37 | 0.37 | 0.39 | 0.44 | 0.47 |
PB Ratio | 0.73 | 0.77 | 0.80 | 0.84 | 0.85 | 0.87 |
P/TBV Ratio | 0.82 | 0.87 | 0.93 | 1.03 | 0.95 | 0.98 |
P/FCF Ratio | - | - | - | - | - | 20.20 |
P/OCF Ratio | 7.16 | 7.58 | 6.82 | 7.61 | 12.86 | 7.24 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
EV/Sales Ratio | 0.75 | 0.79 | 0.77 | 0.76 | 0.77 | 0.80 |
EV/EBITDA Ratio | 6.59 | 6.87 | 6.64 | 7.66 | 7.52 | 9.09 |
EV/EBIT Ratio | 10.55 | 11.00 | 10.48 | 11.99 | 12.03 | 18.12 |
EV/FCF Ratio | - | - | - | - | - | 34.27 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Debt / Equity Ratio | 1.42 | 1.42 | 1.57 | 1.64 | 1.49 | 1.38 |
Debt / EBITDA Ratio | 5.96 | 5.96 | 6.28 | 7.63 | 7.46 | 8.49 |
Debt / FCF Ratio | - | - | - | - | - | 32.03 |
Net Debt / Equity Ratio | 0.83 | 0.83 | 0.83 | 0.77 | 0.64 | 0.54 |
Net Debt / EBITDA Ratio | 3.47 | 3.47 | 3.31 | 3.57 | 3.19 | 3.35 |
Net Debt / FCF Ratio | -18.82 | -18.82 | -7.20 | -5.74 | -7.78 | 12.63 |
Asset Turnover | 0.70 | 0.70 | 0.68 | 0.69 | 0.65 | 0.63 |
Inventory Turnover | 3.05 | 3.05 | 3.29 | 3.81 | 4.02 | 3.81 |
Quick Ratio | 0.51 | 0.51 | 0.55 | 0.85 | 0.94 | 0.98 |
Current Ratio | 0.85 | 0.85 | 0.86 | 1.25 | 1.34 | 1.30 |
Return on Equity (ROE) | 7.58% | 7.58% | 10.07% | 9.19% | 8.64% | 5.87% |
Return on Assets (ROA) | 3.14% | 3.14% | 3.15% | 2.72% | 2.61% | 1.73% |
Return on Invested Capital (ROIC) | 4.95% | 5.17% | 6.13% | 5.41% | 5.76% | 3.24% |
Return on Capital Employed (ROCE) | 10.60% | 10.60% | 10.60% | 6.50% | 6.20% | 4.20% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 5, 2026 | Aug '26 Aug 31, 2026 | Aug '25 Aug 31, 2025 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 |
Earnings Yield | 10.04% | 9.43% | 11.89% | 10.69% | 9.91% | 6.80% |
FCF Yield | -6.04% | -5.70% | -14.39% | -15.93% | -9.66% | 4.95% |
Dividend Yield | 5.33% | 4.58% | 3.94% | 3.60% | 3.45% | 3.90% |
Payout Ratio | 42.90% | 42.91% | 29.97% | 33.39% | 34.94% | 57.28% |
Buyback Yield / Dilution | -2.81% | -2.81% | -0.12% | 0.01% | 0.47% | -0.36% |
Total Shareholder Return | 2.52% | 1.77% | 3.82% | 3.61% | 3.93% | 3.54% |